Literature DB >> 21406501

Inhibition of glyceroneogenesis by histone deacetylase 3 contributes to lipodystrophy in mice with adipose tissue inflammation.

Jin Zhang1, Tara M Henagan, Zhanguo Gao, Jianping Ye.   

Abstract

We have reported that the nuclear factor-κB (NF-κB) induces chronic inflammation in the adipose tissue of p65 transgenic (Tg) mice, in which the NF-κB subunit p65 (RelA) is overexpressed from the adipocyte protein 2 (aP2) gene promoter. Tg mice suffer a mild lipodystrophy and exhibit deficiency in adipocyte differentiation. To understand molecular mechanism of the defect in adipocytes, we investigated glyceroneogenesis by examining the activity of cytosolic phosphoenolpyruvate carboxykinase (PEPCK) in adipocytes. In aP2-p65 Tg mice, Pepck expression is inhibited at both the mRNA and protein levels in adipose tissue. The mRNA reduction is a consequence of transcriptional inhibition but not alteration in mRNA stability. The Pepck gene promoter is inhibited by NF-κB, which enhances the corepressor activity through activation of histone deacetylase 3 (HDAC3) in the nucleus. HDAC3 suppresses Pepck transcription by inhibiting the transcriptional activators, peroxisome proliferator-activated receptor-γ, and cAMP response element binding protein. The NF-κB activity is abolished by Hdac3 knockdown or inhibition of HDAC3 catalytic activity. In a chromatin immunoprecipitation assay, HDAC3 interacts with peroxisome proliferator-activated receptor-γ and cAMP response element binding protein in the Pepck promoter when NF-κB is activated by TNF-α. These results suggest that HDAC3 mediates NF-κB activity to repress Pepck transcription. This mechanism is responsible for inhibition of glyceroneogenesis in adipocytes, which contributes to lipodystrophy in the aP2-p65 Tg mice.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21406501      PMCID: PMC3075929          DOI: 10.1210/en.2010-0828

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  55 in total

1.  CREB regulates hepatic gluconeogenesis through the coactivator PGC-1.

Authors:  S Herzig; F Long; U S Jhala; S Hedrick; R Quinn; A Bauer; D Rudolph; G Schutz; C Yoon; P Puigserver; B Spiegelman; M Montminy
Journal:  Nature       Date:  2001-09-13       Impact factor: 49.962

2.  Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.

Authors:  J C Yoon; P Puigserver; G Chen; J Donovan; Z Wu; J Rhee; G Adelmant; J Stafford; C R Kahn; D K Granner; C B Newgard; B M Spiegelman
Journal:  Nature       Date:  2001-09-13       Impact factor: 49.962

3.  A mutation in the peroxisome proliferator-activated receptor gamma-binding site in the gene for the cytosolic form of phosphoenolpyruvate carboxykinase reduces adipose tissue size and fat content in mice.

Authors:  Yael Olswang; Hannah Cohen; Orit Papo; Hanoch Cassuto; Colleen M Croniger; Parvin Hakimi; Shirley M Tilghman; Richard W Hanson; Lea Reshef
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

4.  Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha.

Authors:  Constantinos Koumenis; Christine Naczki; Marianne Koritzinsky; Sally Rastani; Alan Diehl; Nahum Sonenberg; Antonis Koromilas; Bradly G Wouters
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

5.  Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis.

Authors:  Liza Makowski; Jeffrey B Boord; Kazuhisa Maeda; Vladimir R Babaev; K Teoman Uysal; Maureen A Morgan; Rex A Parker; Jill Suttles; Sergio Fazio; Gökhan S Hotamisligil; MacRae F Linton
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

6.  Functional domains of histone deacetylase-3.

Authors:  Wen-Ming Yang; Shih-Chang Tsai; Yu-Der Wen; Gyorgy Fejer; Edward Seto
Journal:  J Biol Chem       Date:  2002-01-04       Impact factor: 5.157

7.  The histone deacetylase-3 complex contains nuclear receptor corepressors.

Authors:  Y D Wen; V Perissi; L M Staszewski; W M Yang; A Krones; C K Glass; M G Rosenfeld; E Seto
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

8.  Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance.

Authors:  Sylvie Franckhauser; Sergio Muñoz; Anna Pujol; Alba Casellas; Efren Riu; Pedro Otaegui; Benli Su; Fatima Bosch
Journal:  Diabetes       Date:  2002-03       Impact factor: 9.461

9.  Uncoupling of inflammation and insulin resistance by NF-kappaB in transgenic mice through elevated energy expenditure.

Authors:  Tianyi Tang; Jin Zhang; Jun Yin; Jaroslaw Staszkiewicz; Barbara Gawronska-Kozak; Dae Young Jung; Hwi Jin Ko; Helena Ong; Jason K Kim; Randy Mynatt; Roy J Martin; Michael Keenan; Zhanguo Gao; Jianping Ye
Journal:  J Biol Chem       Date:  2009-12-17       Impact factor: 5.157

10.  Insulin inhibits hepatocellular glucose production by utilizing liver-enriched transcriptional inhibitory protein to disrupt the association of CREB-binding protein and RNA polymerase II with the phosphoenolpyruvate carboxykinase gene promoter.

Authors:  David T Duong; Mary E Waltner-Law; Rosalie Sears; Linda Sealy; Daryl K Granner
Journal:  J Biol Chem       Date:  2002-06-17       Impact factor: 5.157

View more
  16 in total

Review 1.  New insights into insulin: The anti-inflammatory effect and its clinical relevance.

Authors:  Qiang Sun; Jia Li; Feng Gao
Journal:  World J Diabetes       Date:  2014-04-15

Review 2.  Histone Deacetylases and Cardiometabolic Diseases.

Authors:  Kan Hui Yiew; Tapan K Chatterjee; David Y Hui; Neal L Weintraub
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-07-16       Impact factor: 8.311

Review 3.  Histone deacetylases as targets for treatment of multiple diseases.

Authors:  Jinhua Tang; Haidong Yan; Shougang Zhuang
Journal:  Clin Sci (Lond)       Date:  2013-06       Impact factor: 6.124

Review 4.  Why do anti-inflammatory therapies fail to improve insulin sensitivity?

Authors:  Zhan-guo Gao; Jian-ping Ye
Journal:  Acta Pharmacol Sin       Date:  2011-10-31       Impact factor: 6.150

5.  Epigenetic regulation of the NR4A orphan nuclear receptor NOR1 by histone acetylation.

Authors:  Yue Zhao; Takashi Nomiyama; Hannes M Findeisen; Hua Qing; Jun Aono; Karrie L Jones; Elizabeth B Heywood; Dennis Bruemmer
Journal:  FEBS Lett       Date:  2014-11-21       Impact factor: 4.124

6.  Disruption of Epithelial HDAC3 in Intestine Prevents Diet-Induced Obesity in Mice.

Authors:  Jordan Whitt; Vivienne Woo; Patrick Lee; Jessica Moncivaiz; Yael Haberman; Lee Denson; Patrick Tso; Theresa Alenghat
Journal:  Gastroenterology       Date:  2018-04-22       Impact factor: 22.682

7.  Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.

Authors:  Youngmi Kim; Kyungjong Kim; Deokbum Park; Eunmi Lee; Hansoo Lee; Yun-Sil Lee; Jongseon Choe; Dooil Jeoung
Journal:  J Biol Chem       Date:  2012-06-07       Impact factor: 5.157

Review 8.  Inflammation during obesity is not all bad: evidence from animal and human studies.

Authors:  Jianping Ye; Owen P McGuinness
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-26       Impact factor: 4.310

9.  Regulation of 11β-HSD1 expression during adipose tissue expansion by hypoxia through different activities of NF-κB and HIF-1α.

Authors:  Jong Han Lee; Zhanguo Gao; Jianping Ye
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-03-19       Impact factor: 4.310

10.  Whole transcriptome RNA-seq reveals key regulatory factors involved in type 2 diabetes pathology in peripheral fat of Asian Indians.

Authors:  Aditya Saxena; Pradeep Tiwari; Nitish Mathur; Sandeep Kumar Mathur
Journal:  Sci Rep       Date:  2021-05-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.